Kyocef-TZ 1gm/125mg Injection
By Kyocef-TZ
Rx
1 Powder for Injection in a Vial

Composition
Ceftriaxone(1gm) + Tazobactum(125mg)

Manufacturer - Lifekyor Pharmaceuticals
b2-1108, palladium, corporate road, behind divya bhaskar, makarba, ahmedabad, gujarat 380051

Expires on or after
October, 2025

liver
When considering using Kyocef-TZ 1gm/125mg Injection, it is important to be cautious if you have severe liver disease. Patients with severe liver issues may require a dose adjustment when using Kyocef-TZ 1gm/125mg Injection. It is advised to consult your doctor before starting this medication in such cases. However, for patients with mild to moderate liver disease, dose adjustment of Kyocef-TZ 1gm/125mg Injection is generally not recommended. Always seek guidance from your healthcare provider when dealing with liver concerns and medication usage.

kidney
Limited information is available regarding the use of Kyocef-TZ 1gm/125mg Injection in patients with kidney disease. It is advised to consult your doctor for proper guidance.

alcohol
It is safe to consume alcohol with Kyocef-TZ 1gm/125mg Injection. No harmful side effects have been reported.

driving
When receiving Kyocef-TZ 1gm/125mg Injection, be cautious as it may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if these effects are present.

pregnancy
Kyocef-TZ 1gm/125mg Injection is typically safe for use during pregnancy based on animal studies. Limited human studies indicate low risks, but consult your doctor for advice.

breastfeeding
Caution should be taken when using Kyocef-TZ 1gm/125mg Injection while breastfeeding. It is advisable to suspend breastfeeding until the mother's treatment is finished and the medication is no longer in her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹200
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025